Case Study
Reducing Time to Launch Evidence Generation by Streamlining Data Source Qualification
Read this case study to see how a large pharma company leveraged advanced search and filtering capabilities to quickly identify relevant data sources for their therapy areas
Dec 26, 2023

A large pharma company, operating in the rare disease therapeutic area, faced a critical challenge: identifying and pre-qualifying relevant real-world data sources swiftly and accurately. They sought to create a reliable repository for future real-world evidence needs, including trial optimization, patient pathway analysis, and therapeutic strategy improvement.

The Challenge: Rarity and Specificity

  • Complex Landscape: The rarity and complexity of the condition demanded a multiplicity of very specific data sources.

The Solution: IQVIA's Health Data Catalog (IHDC)

  • Advanced Search and Filtering: Leveraging IHDC's advanced capabilities, IQVIA identified over 70 relevant data sources across 30+ countries.
  • Quality Assurance: Metadata information for these assets was exported from IHDC, benefiting from the strong quality of data and central orchestration.
  • Unique Maintenance Process: IHDC's unique maintenance process ensures that data asset information remains accurate and up-to-date.

Results and Implications: Efficiency Amplified

  • Swift Identification: In just a few minutes, the client achieved what would typically take days.
  • On-Demand Refreshes: The client can generate on-demand refreshes, ensuring data accuracy and relevancy.

Have questions? Want a demonstration?

We'd love to show you how IQVIA Health Data Catalog can help you assess RWD quickly and easily.

Just send us a message and we'll connect you to a dedicated expert who you can give you a demonstration, customized to your goals and needs.

Contact Us